In order to use cytokines released from biodegradable microspheres to attract MSCs for the treatment of ischemic cardiomyopathy, the first step is to assess whether the SDF-1α is not toxic for tested cells. The gene discussed is CXCL12; the disease is ischemic cardiomyopathy.